The increase in Bifidobacterium modulates inflammation in obese mice, increasing GLP-1 production and reducing intestinal permeability with positive effects on carbohydrate metabolism, favoring a decrease in insulin resistance and improving pancreatic β cell function [59,60]. The gene discussed is GLP1R; the disease is Insulin resistance.